Vireo Growth (VREOF) EBITDA Margin (2020 - 2026)

Vireo Growth's (VREOF) quarterly EBITDA Margin came in at 9.51% in Q1 2026, up 94.0% year-on-year from 4.9% in Q1 2025, and up 16.85% quarter-over-quarter from 8.14% in Q4 2025.

Vireo Growth (VREOF) EBITDA Margin (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed EBITDA Margin across 7 years of filings, most recently posting 9.51% for Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 9.51%, up 94.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.23% (down 591.0% YoY), and the FY2025 annual result was 3.83%, down 1011.0% from the prior year.
  • EBITDA Margin came in at 9.51% for Q1 2026 at Vireo Growth, up from 8.14% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 24.2% in Q3 2023 to a low of 48.62% in Q1 2022.
  • The 5-year median for EBITDA Margin is 4.56% (2022), against an average of 4.9%.
  • Across the five-year window, EBITDA Margin surged 6423 bps in 2022 and tumbled 2676 bps in 2025, its largest moves.
  • Vireo Growth's EBITDA Margin stood at 4.56% in 2022, then jumped by 397 bps to 22.65% in 2023, then sank by 114 bps to 3.08% in 2024, then surged by 364 bps to 8.14% in 2025, then increased by 17 bps to 9.51% in 2026.
  • The last three EBITDA Margin figures came in at 9.51% (Q1 2026), 8.14% (Q4 2025), and 1.49% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 16.37%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 36.83%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 22.39%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -170.35%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -16.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 21.55%
10 Vireo Growth - - 59.30 Mn 9.51%

Historic Data

Download Data
DateValue
Mar 31, 2026 9.51%
Dec 31, 2025 8.14%
Sep 30, 2025 1.49%
Jun 30, 2025 -3.39%
Mar 31, 2025 8.57%
Dec 31, 2024 -3.08%
Sep 30, 2024 15.61%
Jun 30, 2024 23.37%
Mar 31, 2024 20.06%
Dec 31, 2023 22.65%
Sep 30, 2023 24.20%
Jun 30, 2023 -4.58%
Mar 31, 2023 2.77%
Dec 31, 2022 4.56%
Sep 30, 2022 -0.11%
Jun 30, 2022 2.23%
Mar 31, 2022 -48.62%
Dec 31, 2021 -59.68%
Sep 30, 2021 -30.16%
Jun 30, 2021 -21.09%